EFFICACY AND VASCULAR REDEVELOPMENT OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGE 2 EARLY-DIAGNOSED FAMILIAL EXUDATIVE VITREORETINOPATHY
Anti-VEGF therapy may effectively regress the high vascular activity of stage 2 early-diagnosed familial exudative vitreoretinopathy and may promote continued vascular growth toward the periphery.
Authors
- Guo Shaoxian (ORCID: https://orcid.org/0000-0001-6424-8986)
- Huanyu Liu (ORCID: https://orcid.org/0000-0002-7944-7395)
- Jie Peng (ORCID: https://orcid.org/0000-0002-4748-3682)
- Haodong Xiao (ORCID: https://orcid.org/0000-0002-9945-9238)
- Peiquan Zhao (ORCID: https://orcid.org/0000-0002-5092-9550)
- Yu Xu (ORCID: https://orcid.org/0000-0002-0574-1460)
- Xuerui Zhang
- Jianing Ren (ORCID: https://orcid.org/0000-0002-3867-1163)
- Mingyang Wang (ORCID: https://orcid.org/0000-0001-7201-5090)
- Wenting Zhang (ORCID: https://orcid.org/0000-0002-8550-8086)
- Haonan Ma
- Yufan Yang (ORCID: https://orcid.org/0000-0001-8123-6119)
- Yang Yuan (ORCID: https://orcid.org/0000-0002-5552-4958)
- Jiawei Yin
Institutions
- Shanghai Jiao Tong University (CN)
- XinHua Hospital (CN)
Publication Details
- Journal
- Retina
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/iae.0000000000004714
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00